Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand 
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing 
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants 
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role 
WINTER HAVEN, Fla., Dec. 02, 2016 -- 3B Medical, Inc. announces that an Administrative Law Judge of the United States International Trade Commission has issued an Initial Determination that ResMed (RMD) failed to satisfy the domestic industry requirement for patents relating to its CPAP masks and nasal pillow products, manufactured in Australia, Singapore and Malaysia. Gary Hnath of Mayer Brown, counsel for 3B/BMC, successfully argued that ResMed did not demonstrate sufficient U.S. content to obtain protection under Section 337 because “ResMed has not demonstrated that the value added by the alleged activities in the U.S. is significant compared to the overall manufacturing cost".
As a result of the decision, the ALJ found no violation of any of the asserted mask patents by 3B/BMC, resulting in a total victory for 3B/BMC in the ITC’s investigation. ResMed previously abandoned its appeal of the ITC’s finding that ResMed’s patent on its CPAP humidifier was invalid.
About 3B:
3B Medical is a leader in the development, marketing and distribution of medical products for the treatment of sleep disordered breathing and oxygen therapy.
Contacts: For News Media Rebecca Velazquez 3B Medical, Inc. 799 Overlook Drive Winter Haven, FL 33884 Email: [email protected] Tel: (863) 226-6285 ext. 108
